Health Literacy and the Oncology Patient
Release date: September 4, 2019
Expiration date: September 4, 2022
ACPE credit must be claimed by: September 4, 2022
Offered On-Demand only.
This webinar is also part of the 2019 ACPE Webinar Bundle
Register for 2019 ACPE Webinar Bundle
Course Description
Pharmacists are lacking information and education regarding Health Literacy. In the oncology field, it is very important for patients to have excellent health literacy to understand complicated regimens and medication information. This session will focus on tips for the oncology pharmacist on how to create and assess information appropriate for patients using health literacy information and levels.
Learning Objectives
- Review health literacy definitions and current literacy levels.
- Describe the process for creating patient information that is on the appropriate literacy level for patients.
- Determine strategies for identifying patients’ health literacy and incorporating that into the patient-pharmacist interaction.
Speaker
Rebecca (Becky) Fahrenbruch, PharmD BCOP
Oncology Pharmacy Manager at University of Minnesota Health Oncology Infusion Pharmacy
Rebecca (Becky) Fahrenbruch, PharmD, BCOP graduated from University of Nebraska Medical Center with her Doctorate of Pharmacy. She then completed a Pharmacy Practice Residency at Southwest Washington Medical Center, an Oncology Specialty Residency at MD Anderson Cancer Center and became a Board Certified Oncology Pharmacist in 2002. She is the current Oncology Pharmacy Manager at University of Minnesota Health Oncology Infusion Pharmacy in Maple Grove, Residency Program Director for PGY2 Oncology Residency, and Clinical Assistant Professor at the University of Minnesota COP. She continues to be involved in leadership roles, committee work, and speaks for many local and national organizations.
Disclosures
Tesano, UMOEN, Amgen , Exelixis, BMS, Takeda, Kappa Psi Pharmaceutical Foundation, Oncology Reimbursement Management
Target Audience
This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-19-057-H04-P.
Activity Type
Knowledge
Cost
HOPA Member ‒ $20
Nonmember ‒ $40
Accreditation Statement:
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test. ACPE credit must be claimed by September 4, 2022.
Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.
If you have questions about this webinar, please contact HOPA's Education Support at This email address is being protected from spambots. You need JavaScript enabled to view it..
